Feasibility of Early Gabapentin as an Intervention for Neurorecovery
Clinical trial NCT05302999 · RECRUITING
Trial details
- NCT number
- NCT05302999
- Sponsor
- MetroHealth Medical Center
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2026-08-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.